Showing results (251-260 of 325) with videos related to

Sort By:
Pageof 33
American Journal of Hematology|September 1, 1988
Neonatal and maternal platelets: activation at time of birthC R Suarez, J Gonzalez, C Menendez, et al.
Clinical Chemistry|August 14, 1998
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromesJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Ecarin clotting time is sensitive to heparinoids: comparison of two different techniquesM Demir, O Iqbal, B Untch, et al.
Haemostasis|January 1, 1991
Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis modelC Doutremepuich, M C Lalanne, F Doutremepuich, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Influence of different anticoagulant agents on fibrinopeptide a generationM Tobu, O Iqbal, H L Messmore, et al.
Clinical Cardiology|July 1, 1996
Coagulation and fibrinolytic parameters in patients with pulmonary hypertensionR Altman, A Scazziota, J Rouvier, et al.
The Journal of Trauma|May 1, 1996
Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary resultsD G Jacobs, J J Piotrowski, D A Hoppensteadt, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparinZ Shriver, M Sundaram, G Venkataraman, et al.
Thrombosis Research|July 4, 2001
Heparin and a cyclic octaphenol-octasulfonic acid (GL-522-Y-1) bind with high affinity to a 47-kda protein from vascular endothelial cell surface and stimulate the synthesis and structural changes of heparan sulfate proteoglycanM A Pinhal, E S Trindade, J Fareed, et al.
Biochemical Pharmacology|March 29, 1994
Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studiesR J Linhardt, U R Desai, J Liu, et al.
Pageof 33